Acasti Pharma Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ACST New York 2834 https://www.acastipharma.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Acasti Pharma Inc

Acasti Pharma Inc. Retains Lytham Partners to Lead Strategic Investor Relations and Shareholder Communication Program - May 23rd, 2022 8:15 pm
Acasti Pharma's IV Hemorrhage Drug Candidate At Par With Oral Nimodipine - May 18th, 2022 3:20 pm
Acasti Pharma Announces Positive Results for Pharmacokinetic Bridging Study, With Intravenous GTX-104 Meeting All Endpoints - May 18th, 2022 11:30 am
Update: Acasti Pharma CEO to Present at Microcap Rodeo’s Spring into Action Best Ideas Virtual Conference on May 18th - May 16th, 2022 5:30 pm
36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022 - May 16th, 2022 5:20 pm
Acasti Pharma CEO to Present at Microcap Rodeo's Spring into Action Best Ideas Virtual Conference on May 16th - May 12th, 2022 12:00 pm
10 Biotech Penny Stocks Redditors Love - May 6th, 2022 1:02 pm
Acasti Pharma to Present at the B. Riley Securities' 2022 Virtual Neuro & Ophthalmology Conference on April 28th - Apr 25th, 2022 12:30 pm
Acasti Pharma Appoints Healthcare Industry Leader Michael L. Derby to its Board of Directors - Mar 25th, 2022 11:30 am
Acasti Pharma Announces Patents for GTX-104 in Europe, GTX-102 in the U.S. and GTX-101 in Japan - Mar 22nd, 2022 11:30 am
Acasti Pharma CEO to Present at the 32nd Annual Oppenheimer Healthcare Conference on March 16th - Mar 9th, 2022 1:30 pm
Acasti Pharma Celebrates Rare Disease Day - Feb 28th, 2022 1:30 pm
New Strong Sell Stocks for February 23rd - Feb 23rd, 2022 2:50 pm
Acasti Pharma Inc. CEO, Jan D'Alvise, Is Featured on The Stock Day Podcast - Feb 22nd, 2022 2:09 pm
Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2022 - Feb 14th, 2022 12:00 pm
Acasti Pharma Schedules Third Quarter Fiscal 2022 Business Update Conference Call - Feb 7th, 2022 1:30 pm
Acasti Pharma to Present at the H.C. Wainwright BioConnect 2022 Conference - Jan 3rd, 2022 1:30 pm
BLITF Stock: 7 Thing to Know About Mobile Gaming Play i3 Interactive as Shares Rocket Today - Dec 23rd, 2021 3:49 pm
ACST Stock Price Predictions: Why One Analyst Sees Acasti Rocketing to $6 - Dec 22nd, 2021 8:40 pm
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday - Dec 22nd, 2021 12:28 pm